MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-PY-03-0003055
Phoenix Biologicals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.25 Cr
▲ 3% YoY
Net profit · FY 2024
₹7.07 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹59.85 Lakh
EBITDA margin 3.5%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.18 Cr
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹1.46 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
61
Provident fund records
About Phoenix Biologicals Private Limited
Data last updated:
Phoenix Biologicals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2010PTC076804. Its GSTIN is 34AAFCP6631C1ZQ (Puducherry). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.18 Cr. It is led by directors Ramakrishnan Chockalingam and Subramanian Venkataraman.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.25 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹7.07 Lakh (net margin 0.4%) and EBITDA of ₹59.85 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 27% over five years.
The company has about 61 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Phoenix Biologicals. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹1.46 Cr on record. Court records list 10 cases involving the company, including 4 filed by the company and 6 filed against it; 3 cases are pending.
Phoenix Biologicals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0003055). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website phoenixbiologicals.net.
Company details
CIN U24100TN2010PTC076804
Registration Number 076804
Incorporation Date 30 July 2010
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0003055
Recognitions & Rankings of Phoenix Biologicals
Contact details
Phoenix Biologicals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is phoenixbiologicals.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNew No 10, Nakeeran Street, Chennai, Tamil Nadu, India – 600033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Phoenix Biologicals Private Limited, buy the company report.
Comprehensive company report
Phoenix Biologicals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Phoenix Biologicals operates one associated brand: Phoenix Biologicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces pharmaceutical tablets, capsules, ointments, and drugs for export. | phoenixbiologicals.net |
Business activity
The main business activity of Phoenix Biologicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Phoenix Biologicals Private Limited, buy the company report.
Financials of Phoenix Biologicals Private Limited
FY 2024 filings availablePhoenix Biologicals Private Limited reported revenue of ₹17.25 Cr (up 3% YoY) for FY 2024.
Revenue · FY 2024
₹17.25 Cr ▲ 3%
Net profit · FY 2024
₹7.07 Lakh margin 0.4%
EBITDA · FY 2024
₹59.85 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 4%
5 years · compounded
▲ 27%
EBITDA CAGR growth
3 years · compounded
▼ 5%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 3% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹17.25 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Phoenix Biologicals Private Limited, buy the company report.
Board of directors of Phoenix Biologicals Private Limited
Phoenix Biologicals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakrishnan Chockalingam | Director | 30 Jul 2010 | 16 Years 2 Months | Current |
| Subramanian Venkataraman | Director | 30 Jul 2010 | 16 Years 2 Months | Current |
Peer comparison
Phoenix Biologicals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Watertech Pharma Limited | ₹17.36 Cr (FY 2024) | 259.0% | Mohali, Punjab, India | |||
| G P T Pharmaceuticals Private Limited | ₹17.31 Cr (FY 2025) | 46.0% | Hyderabad, Telangana, India | |||
| Kentreck Laboratories Pvt Ltd | ₹17.3 Cr (FY 2025) | 0.0% | Ahmedabad, Gujarat, India | |||
| Phoenix Biologicals Private Limitedthis company | ₹17.25 Cr (FY 2024) | ₹7.07 Lakh | 0.4% | 3.0% | 61 | Chennai, Tamil Nadu, India |
| Para Products Private Limited | ₹17.22 Cr (FY 2025) | -70.0% | New Delhi, Delhi, India | |||
| Matish Healthcare Private Limited | ₹17.22 Cr (FY 2024) | -10.0% | Vadodara, Gujarat, India | |||
| Rangodadhi Chemicals Private Limited | ₹17.2 Cr (FY 2025) | -18.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Phoenix Biologicals Private Limited, buy the company report.
Auditor
Phoenix Biologicals Private Limited is audited by VADLAKUNTA ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VADLAKUNTA ASSOCIATES | FY 2024 | 004484S |
Shareholding
The shareholding of Phoenix Biologicals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Phoenix Biologicals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹1.46 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2024 | 100961548 | Axis Bank Limited | ₹2 Cr | Open | |
| 20 Jan 2012 | 10354969 | Indian Overseas Bank | ₹1.3 Cr | Satisfied | |
| 14 Jul 2011 | 10298121 | Indian Overseas Bank | ₹16 Lakh | Satisfied |
To see the full charge records of Phoenix Biologicals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Phoenix Biologicals Private Limited has 10 court cases on record: 4 filed by Phoenix Biologicals, 6 filed against it. 3 cases are pending and 7 are disposed.
Total cases
10
Filed by the company
4
Filed against the company
6
Pending
3
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 6 | 3 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Appeal | Filed against the company by Ms Pavan Biologicals Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed by the company against Kopran Research Laboratories Limited and 1 other | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI M A) | Filed by the company against Kopran Research Laboratories Limited and 1 other | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI BAIL APPLN) | Filed by the company against Kopran Research Laboratories Limited and 1 other | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by Kopran Research Laboratories Ltd Th.Mr. Manoj Joshi | Disposed |
To see the full case history of Phoenix Biologicals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Phoenix Biologicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Phoenix Biologicals Private Limited has a workforce of 61 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
Employee count
61
Active EPFO establishments
1
GST
Phoenix Biologicals has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AAFCP6631C1ZQ | Puducherry | Active | 01 Jul 2017 |
| 18AAFCP6631C1ZK | Assam | Active | 13 Jan 2020 |
To see the full GST registrations and return filing status of Phoenix Biologicals Private Limited, buy the company report.
Recent activity
Phoenix Biologicals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Ramakrishnan Chockalingam was appointed as Director on 30 Jul 2010.
Charges
A charge with Axis Bank Limited of Rs. 2.00 Cr registered on 20 Jul 2024 with Charge ID 100961548 was modified on 19 Dec 2024.
AGM
Phoenix Biologicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 20 Jan 2012 via Charge ID 10354969 with Indian Overseas Bank was fully satisfied on 21 Aug 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100961548 was registered on 20 Jul 2024.
Filing
Phoenix Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Indian Overseas Bank of Rs. 1.30 Cr registered on 20 Jan 2012 with Charge ID 10354969 was modified on 25 Aug 2023.
Charges
A charge registered on 14 Jul 2011 via Charge ID 10298121 with Indian Overseas Bank was fully satisfied on 05 Jan 2017.
Charges
A charge with Indian Overseas Bank amounted to Rs. 1.30 Cr with Charge ID 10354969 was registered on 20 Jan 2012.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.16 Cr with Charge ID 10298121 was registered on 14 Jul 2011.
Appointed
Ramakrishnan Chockalingam was appointed as Director.
Appointed
Subramanian Venkataraman was appointed as Director.
Incorporation
30 Jul 2010
Phoenix Biologicals Private Limited was registered on 30 Jul 2010 with Roc Chennai & aged 16 years 2 months as per MCA records.
Frequently asked questions
Phoenix Biologicals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 2010 (16+ years old) and is registered under CIN U24100TN2010PTC076804.
Phoenix Biologicals has 2 current directors:
- Ramakrishnan Chockalingam - Director
- Subramanian Venkataraman - Director
The latest financial statements of Phoenix Biologicals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Phoenix Biologicals is 34AAFCP6631C1ZQ, registered in Puducherry. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 18AAFCP6631C1ZK (Assam).
The CIN (Corporate Identification Number) of Phoenix Biologicals is U24100TN2010PTC076804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Phoenix Biologicals has 10 court cases on record: 4 filed by the company and 6 filed against it. 3 are pending.
Phoenix Biologicals was incorporated on 30 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Phoenix Biologicals by revenue are Watertech Pharma Limited, G P T Pharmaceuticals Private Limited, Kentreck Laboratories Pvt Ltd, Para Products Private Limited, Matish Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramakrishnan Chockalingam was appointed as Director on 30 Jul 2010. Subramanian Venkataraman was appointed as Director on 30 Jul 2010.
Yes, Phoenix Biologicals is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0003055).
Phoenix Biologicals can be reached through the website phoenixbiologicals.net. Its registered office is in Chennai, Tamil Nadu, India.